CClinicalTrials.gg
Active, not recruitingNCT07257276PRS-3DCTUpdated Dec 2, 2025

3D-CT-Based Prediction of Difficult Laryngoscopy in Infants With Pierre Robin Sequence

An observational study in Pierre Robin Sequence (PRS), Difficult Laryngoscopy and Airway Management, sponsored by Nanjing Children's Hospital. Active, not recruiting at 1 site in China. Open to participants aged 0 Days to 3 Months. Per ClinicalTrials.gov, last updated 2025-12-02.

Sponsored by Nanjing Children's Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
294
Ages
0 Days to 3 Months
Sex
All
01

Study summary

This study aims to develop and validate a quantitative prediction model using three-dimensional computed tomography (3D-CT) imaging for identifying infants with Pierre Robin sequence (PRS) at risk of difficult laryngoscopy. A dual-parameter model incorporating the oropharyngeal sagittal area (S2) and the distance between the tongue base and the posterior pharyngeal wall (D4) will be established. Internal validation will be performed using data from PRS infants treated between 2023 and 2024, and temporal external validation will be conducted using an independent cohort from 2025.

This study seeks to provide an accurate, non-invasive tool for preoperative airway risk assessment in PRS infants, thereby improving anesthetic safety and clinical decision-making.

Read the detailed description

This retrospective cohort study includes infants diagnosed with Pierre Robin sequence (PRS) who underwent mandibular distraction osteogenesis at the Children's Hospital of Nanjing Medical University between January 2023 and September 2025. Preoperative three-dimensional computed tomography (3D-CT) scans will be used to measure quantitative airway parameters, including the oropharyngeal sagittal area (S2) and the distance from the tongue base to the posterior pharyngeal wall (D4).

According to Cormack-Lehane grades obtained during laryngoscopy, infants will be classified into easy (grades I-II) and difficult (grades III-IV) exposure groups. Logistic regression will be used to identify independent predictors of difficult laryngoscopy, and a dual-parameter model combining S2 and D4 will be developed. The model's discrimination, calibration, and clinical usefulness will be assessed by receiver operating characteristic (ROC) curve analysis, calibration plots, and decision curve analysis (DCA).

Internal validation will be performed using bootstrap resampling (1000 iterations), and temporal external validation will be conducted using an independent cohort from 2025. The goal of this study is to construct a simple, objective, and reproducible model that can improve preoperative airway risk evaluation and support anesthetic management in PRS infants.

02

Conditions studied

  • Pierre Robin Sequence (PRS)
  • Difficult Laryngoscopy
  • Airway Management

Keywords

  • 3D-CT
  • Quantitative Imaging
  • Difficult Airway
  • Infants
  • Prediction Model
  • Pierre Robin Sequence
03

Who can participate

Ages eligible
0 Days to 3 Months
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study included infants diagnosed with Pierre Robin sequence who underwent mandibular distraction osteogenesis under general anesthesia at Nanjing Children's Hospital between January 2023 and December 2025. All participants had complete preoperative 3D-CT imaging and intraoperative laryngoscopic grading records.

Eligibility criteria

Inclusion Criteria:Infants diagnosed with Pierre Robin sequence (PRS) based on mandibular hypoplasia, glossoptosis, and upper airway obstruction.

Undergoing mandibular distraction osteogenesis under general anesthesia.

Complete preoperative 3D-CT imaging data available.

Complete intraoperative laryngoscopic grading recorded (Cormack-Lehane classification).

-

Exclusion Criteria:

  • Presence of other craniofacial syndromes (e.g., Treacher Collins syndrome, Goldenhar syndrome).

Incomplete or poor-quality 3D-CT images.

Missing laryngoscopic grading or intraoperative data.

History of airway surgery before CT imaging.

04

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
294 participants (estimated)
Patient registry
No

Groups and cohorts

  • Easy Laryngoscopy Group

    Infants with Pierre Robin sequence classified as Cormack-Lehane grade I-II during direct laryngoscopy. This group represents patients with easy laryngoscopic exposure.

  • Difficult Laryngoscopy Group

    Infants with Pierre Robin sequence classified as Cormack-Lehane grade III-IV during direct laryngoscopy. This group represents patients with difficult laryngoscopic exposure.

05

What researchers measure

Primary outcomes

  1. Predictive performance of the 3D-CT-based dual-parameter model for difficult laryngoscopy

    The primary outcome is the discriminative ability of the 3D-CT-based dual-parameter model (including S2 and D4) to predict difficult laryngoscopy in infants with Pierre Robin sequence. Predictive performance will be assessed using area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and calibration analysis.

    Time frame: From preoperative imaging (3D-CT) to intraoperative laryngoscopic exposure

06

Study locations

1 site
  • anjing Children's Hospital, Affiliated with Nanjing Medical University
    Nanjing, Jiangsu 210008, China
07

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because this is a retrospective study involving patient privacy-sensitive information.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07257276
Lead sponsor
Nanjing Children's Hospital
Responsible party
Hu Danling (Investigator, Nanjing Children's Hospital) — Principal investigator
First posted
Dec 2, 2025
Start date
Jan 1, 2023
Primary completion
Dec 31, 2024
Completion
Dec 31, 2025 (estimated)
Last update
Dec 2, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion